KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Other Accumulated Expenses (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Other Accumulated Expenses data on record, last reported at $1.7 billion in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 21.55% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 21.55%, while the annual FY2025 figure was $1.7 billion, 21.55% up from the prior year.
  • Other Accumulated Expenses reached $1.7 billion in Q4 2025 per ZBH's latest filing, up from $1.5 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.7 billion in Q4 2025 and bottomed at $1.0 billion in Q2 2022.
  • Average Other Accumulated Expenses over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: soared 45.98% in 2021, then fell 29.96% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $1.3 billion in 2021, then increased by 7.91% to $1.4 billion in 2022, then rose by 8.84% to $1.5 billion in 2023, then dropped by 9.93% to $1.4 billion in 2024, then increased by 21.55% to $1.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1.7 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.